šŸ‘ļø8,962
GitHubLinkedIn
AI in Healthcare and Science••4 min read•655 words

šŸ¤– Koios Medical - SmartUltrasoundā„¢

šŸ‘ļø0reads (human + AI)šŸ¤–0AI ingestions

šŸ¤– Koios Medical - SmartUltrasoundā„¢

This article discusses Koios Medical's SmartUltrasoundā„¢ technology, its commitment to improved patient outcomes, and its use of AI.

Key Points:

• Commitment to trust and better patient outcomes.

• Faster answers for patients.

• Utilizing AI for improved ultrasound technology.

šŸ”— Resources:

• Koios Medical ↗ - Medical technology company

Image

Image


šŸ¤– Recursion Pharmaceuticals - Boltz-2

This article announces the release of Boltz-2, a new open-source co-folding model for protein structure and binding affinity prediction.

Key Points:

• First open-source co-folding model.

• Combines protein structure and binding affinity predictions.

• Measures how strongly a molecule binds to a protein.

šŸ”— Resources:

• Recursion Pharmaceuticals ↗ - Pharmaceutical company

Image

Image


šŸ¤– Proscia - Digital Pathology & AI Congress

This article summarizes Proscia's presence at the Digital Pathology & AI Congress in Philadelphia.

Key Points:

• Networking with leaders in the field.

• Showcasing their technology to top pharmaceutical companies.

• Active participation in shaping the future of medicine.

šŸ”— Resources:

• Proscia ↗ - Digital pathology company

Image

Image


šŸ’” Prediction Health - Hiring and Retaining Rehab Therapists

This article discusses a webinar on strategies for hiring and retaining top rehab therapists.

Key Points:

• Focuses on strategies for attracting and retaining top talent.

• Partnership with MEGbusiness for the webinar.

• Proven strategies for success in hiring and retention.

šŸ”— Resources:

• Prediction Health ↗ - Healthcare company

Image

Image


šŸ¤– Recursion Pharmaceuticals - Investor Conferences

This article announces Recursion Pharmaceuticals' participation in upcoming investor conferences.

Key Points:

• Discussion of AI and machine learning in drug discovery.

• Focus on improving speed, cost, and efficiency.

• Participation of Recursion CFO, Ben Taylor.

šŸ”— Resources:

• Recursion Pharmaceuticals ↗ - Pharmaceutical company

Image

Image


šŸ¤– Perimeter Medical - OCT Technology

This article discusses the history of Optical Coherence Tomography (OCT) technology, highlighting its 40+ year history and Perimeter Medical's expansion of its use.

Key Points:

• OCT technology has a 40+ year history.

• Pioneering paper by Michael Duguay of AT&T Bell Labs in 1971.

• Perimeter Medical's expansion of OCT's applications.

šŸ”— Resources:

• Perimeter Medical ↗ - Medical technology company

Image

Image


šŸ¤– Truveta - ISPOR Webinar

This article announces a webinar hosted by Truveta and ISPOR discussing healthcare trends.

Key Points:

• Webinar hosted by Truveta and ISPOR.

• Discussion of trends in healthcare data.

• Participation of Truveta's Chief Medical Officer and co-founder, Dr. Ryan Ahern, and Principal Research Analyst Brianna Cartwright.

šŸ”— Resources:

• Truveta ↗ - Healthcare data company

Image

Image


šŸ¤– IBEX Medical Analytics - Clinical-Grade Machine Learning Tools

This article announces a new series evaluating clinical-grade machine learning tools for cancer diagnosis, starting with prostate adenocarcinoma.

Key Points:

• New series evaluating clinical-grade machine learning tools.

• Focus on prostate adenocarcinoma diagnosis.

• Granular dive into methods, wins, and flaws of the IBEX algorithm.

šŸ”— Resources:

• IBEX Medical Analytics ↗ - Medical analytics company

Image

Image


šŸ¤– Ambience AI - Case Study: Alpine Physician Partners

This article highlights a case study showcasing the benefits of Ambient AI for reducing burnout and improving clinician efficiency at Alpine Physician Partners.

Key Points:

• 32% reduction in feelings of burnout.

• 3.4 hours saved per clinician per day on documentation.

• 9-point improvement in clinician NPS.

šŸ”— Resources:

• Ambience AI ↗ - AI-powered healthcare solutions


šŸ¤– Truveta - GLP-1 Prescriptions in Adolescents

This article discusses a Truveta Research study on the increase in GLP-1 prescriptions among adolescents.

Key Points:

• Study of over 1.2 million adolescents (ages 12-17).

• GLP-1 prescriptions were 1.5x higher in 2024 than in 2023.

• Exclusive analysis with Reuters.

šŸ”— Resources:

• Truveta ↗ - Healthcare data company

Image

Image


ā­ļø Support

If you liked reading this report, please star ā­ļø this repository and follow me on Github ↗, š• (previously known as Twitter) ↗ to help others discover these resources and regular updates.


Related AI in Healthcare and Science Breakdowns

Drix10
Written by Drix10

Co founder @ PartPilot | 1 x Acquired Founder | Canopy @ f.inc | Cybersec @ DSU | 2x International Hackathon šŸ†. Read more on drix10.com.